What is Mydawa?
Founded in 2017, Mydawa operates as a comprehensive technology-driven health platform. The company provides a holistic suite of services, including online doctor consultations, diagnostic lab testing, e-prescriptions, and chronic-care management. By integrating these essential services into a single digital interface, Mydawa addresses critical gaps in the healthcare delivery chain, ensuring that patients in Kenya and Uganda have reliable access to medication and professional medical advice.
The company's business model is designed to streamline the patient journey, reducing the friction typically associated with traditional healthcare access. Through its digital-first approach, Mydawa has established itself as a vital component of the regional health-tech infrastructure, effectively bridging the divide between patients and high-quality medical resources.
How much funding has Mydawa raised?
Mydawa has raised a total of $20M across 1 funding round:
Other Financing Round
$20M
Other Financing Round (2023): $20M with participation from Alta Semper Capital
Key Investors in Mydawa
Alta Semper Capital
Alta Semper is a frontier-markets private equity firm that invests flexible and strategic capital into healthcare and consumer opportunities across African markets. The firm focuses on market-leading platforms with regional aspirations, aiming to forge lasting partnerships with companies, founders, and other investors.
What's next for Mydawa?
Looking ahead, Mydawa is poised to leverage its recent capital infusion to scale its operations and deepen its penetration in existing markets. The strategic focus will likely center on enhancing the platform's diagnostic capabilities and expanding its chronic-care management offerings to meet the growing demand for accessible, long-term health solutions.
As the company matures, the emphasis will shift toward optimizing operational efficiencies and exploring potential expansion into adjacent territories. By maintaining its focus on technology-driven healthcare, Mydawa is set to remain a key driver of innovation in the African health-tech sector, attracting further interest from institutional investors seeking exposure to high-growth frontier markets.
